Gapping up
In reaction to earnings/guidance:
- GCI +3.3%
Select oil/gas related names showing strength:
- RDS.A +3%, BP +2.5%, HAL +2.5%, SLB +2.3%, TTE +2%, XOM +1.7%, XLE +1.6%, USO +1.6%, OIH +1.4%, .
Other news:
- LICY +6.6% (positive Barrons article)
- ALT +5.5% (positive Barrons article)
- GGPI +3.7% (Polestar signs agreement to be publicly listed through combination with Gores Guggenheim)
- EVLO +3.4% (reports Phase 2 clinical data with EDP1815 in psoriasis)
- XLRN +3.2% (is in advanced talks to be acquired by a large company, according to Bloomberg)
- NRXP +2.8% (announces improved survival at one year in highly comorbid COVID-19 patients treated with ZYESAMI)
- SMG +2.7% (positive Barrons article)
- SNDX +2% (Syndax Pharmaceuticals and Incyte (INCY) to collaborate to develop Axatilimab; Syndax to receive $ 152 million in cash)
- CIFR +1.8% (files for 42,035,500 share common stock offering by selling shareholders)
- BCRX +1.1% (positive Barrons article)
Analyst comments:
- DSP +4.9% (upgraded to Mkt Outperform from Mkt Perform at JMP Securities)
- BOX +1.9% (upgraded to Mkt Outperform from Mkt Perform at JMP Securities)
- NATI +1.7% (upgraded to Buy from Neutral at Goldman)
- BBWI +1.2% (upgraded to Overweight from Neutral at Atlantic Equities)
- CPT +0.9% (upgraded to Buy from Neutral at BofA Securities)